Megan Macejko Healthcare Provider

I am going on my 10th year as an Oncology Nurse and my entire nursing career has been taking care of people with cancer. The last 6-7 years, I have primarily worked with hematologic malignancies and bone marrow transplant patients, and I am currently a nurse clinician for Dr. Saulius Girnius, a hematologist who specializes in Multiple Myeloma. I have watched an incredible transformation in the way we fight Multiple Myeloma over the last 10 years. I have watched drugs be rushed approved by the FDA, and I have witnessed the lives of my patients and their families change because of these new therapies. I am incredibly passionate about research and I am so excited to have this opportunity to raise money for MMRF and to be a part of the Road to Victories team. This is my official cycling event and I am really looking forward to the ride in September

Sorry, there are no posts from this member.
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More